Page last updated: 2024-09-03

gefitinib and betulin

gefitinib has been researched along with betulin in 2 studies

Compound Research Comparison

Studies
(gefitinib)
Trials
(gefitinib)
Recent Studies (post-2010)
(gefitinib)
Studies
(betulin)
Trials
(betulin)
Recent Studies (post-2010) (betulin)
5,2315662,9194228287

Protein Interaction Comparison

ProteinTaxonomygefitinib (IC50)betulin (IC50)
Transcription factor p65Homo sapiens (human)8.8

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Huang, G; Jia, W; Li, J; Liu, J; Liu, L; Miao, P; Song, S; Sun, X; Yan, H; Yang, H; Zhao, L; Zhao, X; Zhou, X1
Cai, J; Ding, XB; Gong, YS; Wang, JN; Yan, WY1

Other Studies

2 other study(ies) available for gefitinib and betulin

ArticleYear
Inhibition of SREBP increases gefitinib sensitivity in non-small cell lung cancer cells.
    Oncotarget, 2016, Aug-09, Volume: 7, Issue:32

    Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Gefitinib; Humans; Hydroxycholesterols; Lung Neoplasms; Membrane Proteins; Mice; Mice, Nude; Microtubule-Associated Proteins; Protein Kinase Inhibitors; Pyridines; Quinazolines; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Thiazoles; Triterpenes; Xenograft Model Antitumor Assays

2016
Co-treatment of betulin and gefitinib is effective against EGFR wild-type/KRAS-mutant non-small cell lung cancer by inducing ferroptosis.
    Neoplasma, 2022, Volume: 69, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Ferroptosis; Gefitinib; Humans; Lung Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); Reactive Oxygen Species; Triterpenes

2022